产后高血压的管理及其对再入院率的影响
该回顾性队列研究纳入单中心3年间(2017-2019)分娩的14577名女性,其中3480名(24%)符合围产期高血压定义,176名(5.1%)因高血压并发症再入院,中位再入院时间为出院后3天。出院前12小时内收缩压≥140 mm Hg或舒张压≥90 mm Hg者再入院风险升高,出院时未处方降压药者风险增加32%,处方降压药者调整比值比为2.90(95%CI 1.11-7.57)。
要点
- 出院前12小时内血压≥140/90 mm Hg与再入院风险升高相关。
- 出院时未处方降压药的高血压患者再入院风险增加32%。
- 出院时处方降压药的高血压患者再入院风险约为正常血压出院者的2.90倍(调整OR)。
核心结论
- 出院前12小时内未治疗的高血压与再入院风险升高相关:未处方降压药者风险增加32%,处方降压药者风险约为正常血压出院者的3倍。
研究设计与样本
- 回顾性队列研究,纳入单中心3年间(2017-2019)所有围产期高血压分娩女性,共14577名,其中3480名(24%)符合围产期高血压定义。
主要发现
- 3480名围产期高血压女性中,176名(5.1%)因高血压并发症再入院,中位再入院时间为出院后3天。
- 再入院患者中60%在分娩住院期间被临床医生赋予围产期高血压的国际疾病分类第十版编码。
- 出院前12小时内收缩压≥140 mm Hg或舒张压≥90 mm Hg者再入院风险更高,无论出院时是否处方降压药。
- 与正常血压出院者相比,出院前12小时内有高血压且出院时处方降压药者再入院风险显著增加,调整OR为2.90(95%CI 1.11-7.57)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postpartum hypertension is a source of significant morbidity and mortality in the United States. While advances have been made in the peripartum management of hypertension, there is little data to guide ongoing management postpartum. OBJECTIVE: To determine whether an association exists between (1) hospital readmission and (2) hypertension in the 12 hours before discharge and the prescription of antihypertensive medications at the time of discharge. The secondary objective included evaluating the median time to readmission for hypertensive complications. STUDY DESIGN: This was a retrospective cohort study of all women with peripartum hypertension at a single tertiary care center over a 3-year period (2017-2019). Peripartum hypertension was defined as any systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg on 2 occasions, 4 hours apart, in the electronic medical record during the patients' admission for delivery. As potential risk factors for readmission, we also identified if the patients were discharged with a prescription for antihypertensive medication and assessed the blood pressure measurements during the 12 hours before discharge. The primary outcome of interest was postpartum readmission because of hypertensive complications. Readmission was defined as emergency room evaluation or hospital readmission because of hypertensive complications. Analysis was stratified into 4 comparison groups on the basis of the blood pressure and antihypertensive medications on discharge. The rate of postpartum readmissions was calculated. The risks of readmission were estimated using logistic regression and were adjusted for appropriate confounding variables. RESULTS: Of 14,577 women who gave birth during the study period, 3480 (24%) met the definition of peripartum hypertension. Of those, 176 (5.1%) were readmitted within a median of 3 days from discharge. Sixty percent of patients readmitted had an International Classification of Diseases, Tenth Revision code for peripartum hypertension assigned by providers during their admission. Women with systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg before discharge were at a higher risk of readmission irrespective of being discharged with antihypertensive medication. Compared with those who were discharged normotensive, women who had hypertension in the 12 hours before discharge and were discharged with an antihypertensive prescription were at a significantly increased risk of readmission, adjusted odds ratio, 2.90; 95% confidence interval, 1.11-7.57. CONCLUSION: Untreated hypertension within 12 hours before discharge was associated with a 32% higher risk of readmission in those who were not prescribed antihypertensive medications at discharge and a 3-fold increased risk of readmission in patients discharged on antihypertensive medication. These findings highlight the importance of treatment to normalize the blood pressure for at least 12 hours before discharge.
引用
- Lovgren T, Connealy B, Yao R, et al. Postpartum management of hypertension and effect on readmission rates. Am J Obstet Gynecol MFM. 2021. PMID: 34757235. doi:10.1016/j.ajogmf.2021.100517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。